|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,766.00 GBX | +0.13% |
|
+1.47% | -0.17% |
| 13/05 | ASTRAZENECA : Jefferies remains its Buy rating | ZD |
| 13/05 | AstraZeneca, Owkin to Develop AI Agents for Drug Discovery Decision-making | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.13% | +1.47% | -8.15% | -8.94% | -0.17% | +35.23% | +14.62% | +75.32% | +249.39% | 288B | |
| +2.61% | +2.91% | +9.27% | -2.33% | -5.48% | +36.15% | +133.81% | +421.06% | +1,230.73% | 883B | |
| +2.75% | +2.58% | -3.17% | -5.35% | +11.34% | +55.23% | +43.31% | +35.57% | +102.91% | 540B | |
| +0.31% | +1.69% | +0.98% | -9.94% | -8.75% | +10.90% | +41.69% | +78.82% | +236.29% | 367B | |
| -0.94% | -2.05% | -0.60% | -12.42% | -3.93% | +21.74% | +10.73% | +4.73% | +28.64% | 328B | |
| +0.78% | +1.00% | -3.17% | -6.66% | +6.57% | +29.63% | +26.23% | +45.91% | +59.35% | 283B | |
| +0.96% | -0.10% | -5.58% | -6.56% | +7.78% | +48.05% | -3.15% | +44.17% | +110.56% | 278B | |
| +0.91% | +2.12% | +25.58% | -3.67% | -8.01% | -31.78% | -49.10% | +24.97% | +67.62% | 206B | |
| +0.05% | +1.61% | -3.82% | -8.87% | +2.79% | +24.40% | +44.43% | +33.47% | +120.84% | 181B | |
| -1.40% | -2.38% | -4.30% | -14.15% | +8.40% | +31.17% | +70.21% | +93.08% | +60.88% | 168B | |
| +0.35% | -2.15% | -5.05% | -5.87% | +4.26% | +13.51% | -30.50% | -35.26% | -21.78% | 147B | |
| -0.11% | -0.35% | -2.88% | -7.16% | +4.54% | +21.03% | -17.15% | -13.30% | -20.78% | 115B | |
| +1.06% | +5.94% | +2.96% | -7.82% | -0.07% | +4.88% | +30.41% | +111.36% | +456.72% | 114B | |
| -0.87% | -2.57% | -8.42% | -6.31% | -12.09% | -18.94% | -26.77% | -16.03% | +3.92% | 103B | |
| -0.29% | +0.59% | -13.09% | -12.89% | +3.37% | +38.88% | +28.28% | +11.48% | +3.84% | 102B | |
| +1.01% | -2.66% | -7.51% | -15.10% | -4.40% | +5.07% | +118.10% | +91.26% | +547.67% | 81.31B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| -0.45% | +3.67% | -2.10% | -4.90% | -6.23% | +10.20% | +22.74% | -19.41% | +285.12% | 54.85B | |
| +1.04% | -1.79% | -6.94% | -5.78% | +7.86% | +27.79% | +16.15% | +39.44% | +8.94% | 51.76B | |
| -1.22% | -1.40% | -6.91% | -17.43% | +2.59% | +53.48% | -29.33% | -33.48% | -60.51% | 44.28B | |
| Average | +0.24% | +0.45% | -2.26% | -8.53% | +0.55% | +21.93% | +23.41% | +52.27% | +182.65% | 219.94B | |
| Weighted average by Cap. | +0.53% | +0.97% | +0.32% | -7.10% | +0.25% | +27.58% | +43.43% | +117.06% | +347.98% |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition